Patent US3719683A successfully refreshed from Google Patents.
← Back to Patent Explorer
US3719683A Expired / Lapsed US ⏱️ 0.0 years remaining

Imidazo(4,5-b)pyridines

Assignee: Novartis Corp
•
Filing: 1970-11-20
•
Granted: 1973-03-06
•
Expires: 1990-11-20
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 1-Aminoalkyl-2,3-dihydro-imidazo(4,5-b)pyridines, e.g. those of the formula Am an amino group ALK ALKYLENE WITH AT LEAST 2C X O or S R H, aliphatic, araliphatic or aromatic radical ACYL DERIVATIVES, N-oxides, quaternaries or salts thereof are antidepressants.

Inventors

  • 👤 M Robison
  • 👤 N Finch

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 16:54
CPC Classifications
C; C07; C07D; C07D471/00; C07D471/02; C07D471/04

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 5 words
A 1-aminoalkyl-2,3-dihydro-imidazo-(4,5-b)pyridine of the formula
Claim 2
Dependent Claim 5 words
A 1-aminoalkyl-2,3-dihydro-imidazo-(4,5-b)pyridine of the formula
Claim 3
Dependent Claim 11 words
A compound as claimed in claim 1 and having the formula
Claim 4
Dependent Claim 53 words
A compound as claimed in claim 3, in which formula Am1 is mono- or dimethylamino, p is the integer 2 or 3, X is oxygen R1 is cyclopentyl, cyclohexyl, cycloheptyl, benzyl, (chloro)-benzyl, phenyl, (methoxy)n-phenyl, (fluoro)-phenyl or (chloro)-phenyl and n is an integer from 1 to 3, or therapeutically accept-able acid addition salts thereof.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1976-03-05 1976-09-04 1977-03-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1980-03-05 1980-09-04 1981-03-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1984-03-05 1984-09-04 1985-03-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag